David Nwaba (Houston Rockets) with an assist vs the San Antonio Spurs, 01/16/2021
David Nwaba (Houston Rockets) with an assist vs the San Antonio Spurs, 01/16/2021
Today, Ecopia AI ("Ecopia") announced a partnership with Airbus to produce next-generation digital maps on a global scale—including land use/land cover, roads, and building footprint data. This digital mapping solution will provide commercial and government users with an accurate and up-to-date digital representation of their areas of interest, driving better decision making across industries.
DENVER and VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the "Company" or "Koios") is pleased to announce that its KOIOS™ nootropic beverages and Fit Soda™ functional beverages (collectively, “Koios Beverages”) have been approved for placement at Sprouts Farmers Market (“Sprouts”) (NASDAQ: SFM) who has more than 360 stores in 23 states. With the addition of Sprouts, the brand will now be carried in more than 4,200 stores across various regions of the United States. Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products and a strong focus on customer service among its more than 35,000 team members. Team members are trained to educate customers about the thousands of products offered, which also include cutting-edge vitamins and supplements made using strict quality standards and ethically sourced ingredients. In addition to personalized service, Sprouts offers resources on sprouts.com to educate customers on health topics such as nootropics and cognitive health. The following SKUs of Koios Beverages will be available in Sprouts beginning in April 2021: KOIOS™ Nootropic Beverage: KOIOS™ is designed to naturally support focus, memory, mental drive, clarity, and energy. Apricot VanillaBlack RaspberryBlood OrangePeach MangoPear Guava Fit Soda™ Functional Beverage: Fit Soda™ is designed to deliver nutrients to the body, but still taste like soda. It is infused with BCAAs and electrolytes. Black Cherry ColaOrange CreamRoot Beer Vanilla FloatSparkling Citrus Koios Chief Executive Officer Chris Miller commented, “As a company centered in health and wellness, we’re thrilled to partner with Sprouts as our first national retail partner to carry all nine SKUs simultaneously. Our products are designed to support cognitive function and nutrition, which meets the needs of Sprouts’ shoppers who are looking for innovative and differentiated products made with quality ingredients.” On behalf of the Board of Directors of the Company, KOIOS BEVERAGE CORP. “Chris Miller” Chris Miller, CEO, and Director For further information, please contact: Gina Burrus844firstname.lastname@example.org THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. About Koios Beverage Corp. The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain. Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com. Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential placements following Sprouts’ approval of Koios Beverages to be placed in their supermarkets in the United States. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual's health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease. This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
Incap CorporationPress release on 4 March 2021 at 12.00 p.m. EET Incap Corporation has made a new appointment to its team, promoting the current Plant Director of Incap Electronics Slovakia to the position of Managing Director. The company has decided to promote Miroslav Michalik to the position of Managing Director of Incap Slovakia. Miroslav Michalik has been employed by Incap Slovakia (previously AWS Slovakia) since 2018, working as a Plant Director at the company’s factory in Namestovo. “I am pleased to see Miroslav Michalik move into the Managing Director position of our factory in Slovakia. His previous role as plant manager proved that he’d be a great fit for leading the operations at Incap Slovakia," says Otto Pukk, President and CEO of Incap Group. Miroslav Michalik studied electronics at secondary school and went on to study production and general management at degree-level. Before joining Incap, he held several roles in companies within the electronics sector, from process engineer to plant manager and managing director. “I have worked in the electronics sector for my entire professional career. I am honored to have been entrusted with this new responsibility which encourages me to continue in my mission to develop the entire company to be customer-oriented and performance-driven,” said Miroslav Michalik. Before holding positions at Incap and AWS Group, Miroslav Michalik held the position of managing director at Giesecke+Devrient Slovakia, providing smart payment, ID, passport, and telecommunication card solutions. Prior to that, Miroslav Michalik was a plant manager at Visteon (formerly Johnson Controls Automotive), providing solutions for automotive electronics and infotainment. He also held several positions, including operational manager and team director, at the multinational electronics manufacturing services company, Celestica. Incap’s factory in Slovakia, based in Namestovo, provides a competitive-cost volume manufacturing option for its customers, in addition to featuring a dedicated hall for the automotive business. The factory has operated in the field of electronics manufacturing since 2008. With 5,200 square meters of total floor space and customers from companies all over the world, the factory brings together the high-level technical capabilities and leading-edge production technologies that are normally associated with multinationals, with a customer service approach that is based on offering a highly personalised service. INCAP CORPORATION For additional information, please contact:Otto Pukk, President and CEO at Incap Corporation, tel. +372 508 0798 Photo, Miroslav Michalik: https://photos.app.goo.gl/6Y7MJkwpdxn18MB96 INCAP IN BRIEF Incap Corporation is a trusted partner and full-service provider in Electronics Manufacturing Services. As a global EMS company, Incap supports customers ranging from large multinationals and mid-sized companies to small start-ups in their complete manufacturing value chain. Incap offers state-of-the-art technology backed up by an entrepreneurial culture and highly qualified personnel. The company has operations in Finland, Estonia, India, Slovakia, the UK, and Hong Kong and employs approximately 1,900 people. Incap’s share has been listed on Nasdaq Helsinki Ltd stock exchange since 1997.
Overall Consumer Debt Climbs due to Increased Mortgage ActivityTORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Increased mortgage activity and rising house prices in the fourth quarter of 2020 pushed the overall consumer debt level to $2.07 trillion, up 1.5 per cent from last quarter and up 4.1 per cent from Q4 2019, according to Equifax Canada’s most recent report on consumer credit conditions. Despite the increase in total debt, the average consumer debt (excluding mortgages) dropped again this quarter to $23,043, which is a year-over-year decrease of 3.0 per cent and a decline of 0.8 per cent compared to the previous quarter. The drop in consumer debt is primarily due to credit card balance which has been gradually declining since March last year due to reduced spending and consumers paying down more of their balance on a monthly basis. “This reduction has been a positive consumer shift but that’s not to say we are out of the woods in terms of recovery,” said Rebecca Oakes, AVP of Advanced Analytics at Equifax Canada. “Deferral programs are ending and pockets of financial stress are starting to emerge for some consumers. Credit card spend is also starting to rise again.” Deferrals and delinquencies during the pandemic More than three million Canadians took advantage of credit payment deferrals since the start of the pandemic and four out of five of these have now completely exited the use of deferral programs. Payment deferrals have been instrumental in preventing consumers impacted by the pandemic from becoming delinquent on their debt obligations. Even as consumers come out of deferral programs, the 90+ day delinquency rate for non-mortgage products stayed level in Q4 at 0.98 per cent while the same rate for mortgages was 0.16 per cent. However, early-stage delinquency (where an individual has missed one or two months of payments) continued to rise during Q4. Mortgages saw a 31 per cent increase in the 30+ day delinquency rate, while the 30+ day delinquency rate on installment loans jumped by 76 per cent when compared to Q3 2020. “The numbers suggest recovery will remain very uneven,” added Oakes. “Quebec, for example, has shown early non-mortgage delinquency continue to fall despite consumers leaving deferral programs, whereas Alberta has the highest increase in consumers missing mortgage payments. The support mechanisms across Canada remain pivotal in the prevention of further increased delinquency levels.” First-time homebuyers, low interest rates and lendingHigh demand for housing and lower interest rates continued to fuel new mortgages with a 22.1 per cent year-over-year volume growth in Q4 2020. The average mortgage loan amount rose by 14.4 per cent when compared to Q4 2019, marking the biggest year-over-year jump since 2015. Higher loan amounts can also be attributed to first-time homebuyers who saw higher than average year over year volume growth of 26.9 per cent in Q4 2020. “Rising prices in real estate hot spots have led to first-time homebuyers taking on more mortgage debt than ever in order to get their foot on the property ladder,” said Oakes. “For example, in B.C. we saw average new mortgages for first-time buyers exceed $470K during the last quarter yet they are not being deterred; volumes were up more than 35 per cent compared to the same period in 2019.” New auto finance and installment loans trended down this quarter with an 8.4 per cent and a 21.5 per cent year over year drop respectively, meanwhile, new credit cards are slowly recovering with a 10 per cent increase versus the last quarter. Lenders are also showing some signs of caution as a result of this uncertain period. Consumers are still being offered additional credit, but on higher interest rate products like credit cards, limits on newly-opened cards have been lower for the last two quarters when compared to the same periods in 2019. “During periods of economic uncertainty, consumers and lenders may take proactive action to reduce variability in credit commitments, switching or encouraging the use of lower interest rate products,” said Oakes. “We are still in an uncertain period with some isolated pockets of financial stress emerging. We will continue to closely monitor this over the coming months.” Debt (excluding mortgages) & Delinquency Rates Age Average Debt (Q4 2020)Average Debt Change Year-over-Year (Q4 2020 vs. Q4 2019)Delinquency Rate(Q4 2020)Delinquency Rate Change Year-over-Year (Q4 2020 vs. Q4 2019)18-25$8,747-1.13%1.29%-21.48%26-35$17,868-2.35%1.37%-20.04%36-45$27,893-3.36%1.10%-19.64%46-55$35,252-2.73%0.86%-16.27%56-65$29,369-3.13%0.77%-14.77%65+$15,871-3.76%0.91%-13.90%Canada$23,043-3.02%0.98%-17.52% Major City Analysis – Debt (excluding mortgages) & Delinquency Rates CityAverage Debt (Q4 2020)Average Debt Change Year-over-Year (Q4 2020 vs. Q4 2019)Delinquency Rate(Q4 2020)Delinquency Rate Change Year-over-Year (Q4 2020 vs. Q4 2019)Calgary$28,829-3.22%1.19%-13.60%Edmonton$27,319-3.64%1.43%-10.57%Halifax$22,584-4.16%1.17%-23.12%Montreal$17,103-4.76%0.94%-27.25%Ottawa$21,891-3.82%0.82%-17.23%Toronto$23,200-1.24%1.09%-13.75%Vancouver$26,172-1.59%0.69%-15.02%St. John's$25,155-1.54%1.35%-22.27%Fort McMurray$39,7170.11%1.69%-13.02% Province Analysis - Debt (excluding mortgages) & Delinquency Rates ProvinceAverage Debt (Q4 2020)Average Debt Change Year-over-Year (Q4 2020 vs. Q4 2019)Delinquency Rate(Q4 2020)Delinquency Rate Change Year-over-Year (Q4 2020 vs. Q4 2019)Ontario$23,883-2.14%0.91%-15.31%Quebec$18,888-4.76%0.75%-28.82%Nova Scotia$21,969-2.98%1.37%-23.59%New Brunswick$23,217-2.74%1.51%-18.52%PEI$23,070-0.70%0.96%-21.91%Newfoundland$23,836-0.99%1.40%-23.71%Eastern Region$22,832-2.32%1.40%-21.89%Alberta$28,099-3.36%1.36%-10.96%Manitoba$18,030-4.68%1.21%-17.93%Saskatchewan$23,927-3.48%1.32%-16.54%British Columbia$24,317-2.15%0.83%-14.66%Western Region$24,988-2.95%1.12%-13.60%Canada$23,043-3.02%0.98%-17.52% * Based on Equifax data for Q4 2020 About EquifaxAt Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employees, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by more than 11,000 employees worldwide, Equifax operates or has investments in 25 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.ca and follow the company’s news on LinkedIn. Contact: Andrew FindlaterTom CarrollSELECT Public RelationsEquifax Canada Media Relations email@example.com MediaRelationsCanada@equifax.com (647) 444-1197
Major artificial disc market players include AxioMed, Medtronic, Globus Medical, NuVasive, DePuy Synthes, Paradigm Spine, Spineart, Synergy Disc Replacement, Zimmer Biomet, Orthofix Medical, and B. Braun Melsungen, Stryker.Pune, India, March 04, 2021 (GLOBE NEWSWIRE) -- The global artificial disc market is poised to register healthy gains during the forecast period as technological advancements in surgical material and techniques have carved a niche in the industry. With the demand for minimally invasive surgical procedures soaring, use of minimally invasive disc replacement procedures has gained substantial traction in the past several years. Rising prevalence of degenerative disc and bone disorders has compelled industry leaders to further their investments in the landscape. The emergence of advanced disc has mustered up the confidence of stakeholders. Specifically, the advent of multi-level artificial discs, including ProDisc-C artificial disc will propel the product demand globally. In terms of revenue, the global artificial disc market is likely to grow at a notable pace by 2026. Assessing the industry dynamics, regional trends are likely to play an invaluable role in the landscape. Some of these trends are delineated below: Europe to be replete with investments Traction for cervical artificial discs is likely be noticeable in the U.K., Germany and France following the popularity of minimally invasive disc replacement procedures. These advanced artificial discs boost mobility and minimize the risk of post-surgical complications and negates the chance of infection. Cervical artificial disc segment is likely to expand at a strong CAGR of around 18% through 2026. Over the years, application of metal-on-metal implants has surged in the region, the trend is likely to continue for the next few years. These implants have become popular as an affordable material with high longevity. Access sample pages of the report, “Europe Artificial Disc Market Forecasts 2026” in detail along with the table of contents (ToC) @ https://www.graphicalresearch.com/request/1285/sample Metal implants gain traction in Europe Metal implants such as titanium alloys, cobalt-nickel-chromium-molybdenum, zirconium alloys and tantalum are gaining impetus owing to their tremendous corrosion resistant attributes. Artificial disc market from metal-on-metal segment in Europe is likely to expand at a robust CAGR of around 16% through 2026. The U.K. is likely to come up as a favorable investment hub as leading companies vie to expand their portfolios in the region. A palpable rise in the cases of orthopedic disease has further signified the trend for artificial disc. According to the National Health Service (NHS), around 10 million people suffer from arthritis or similar joint conditions in the U.K. The U.K. artificial disc market was pegged at around USD 85 million in 2019 and will grow noticeably by 2026. Bullish growth outlook is majorly attributed to the prevalence of advanced healthcare facilities and presence of leading players in the country. North America sees impetus for Lumbar artificial disc With technological innovations coming to the fore, North America artificial disc market share is brimming with growth. Lumbar artificial disc surgery has gained impetus in the U.S. and Canada as an ideal alternative to spinal fusion surgery. Considering that lumbar artificial discs minimize recovery time and leverage easy movement, these products are likely to be sought-after across end-use applications. The lumbar artificial disc segment is forecast to grow at a healthy CAGR of around 18% through 2026. Access sample pages of the report, “North America Artificial Disc Market Forecasts 2026” in detail along with the table of contents (ToC) @ https://www.graphicalresearch.com/request/1274/sample Robust demand for metal-on-biopolymer discs in America Traction for metal-on-biopolymer artificial discs will surge in the next few years in the U.S., Canada and Mexico on account of better compatibility, high degree of movement and flexible spine movement. Metal-on-biopolymer segment was valued at more than USD 800 million in 2019 and is forecast to grow at a notable pace by 2026. More importantly, easy insertion and less friction of metal-on-biopolymers have augured well for market participants eyeing to expand their footprint in the region. Leading companies are gearing to infuse funds in the U.S. on the heels of rising cases of orthopedic diseases. According to the CDC, approximately 54 million adults were diagnosed with arthritis in the U.S. in 2015. The U.S. artificial disc market value is forecast to surpass USD 2.5 billion by 2026, partly attributed to soaring healthcare expenditures and technological advancements. Asia Pacific to witness traction for metal-on-metal disc Considering the pervasiveness of low calcium intake in APAC, demand for artificial disc replacement procedures has surged. Specifically, metal-on-metal implants have gained impetus owing to biocompatibility, resistance to corrosion and durability. The artificial disc market from the metal-on-metal segment in APAC is projected to grow at a bullish CAGR of around 18.5% through 2026. India is likely to come up as a lucrative market owing to a drastic rise in road accidents and increasing cases of orthopedic diseases. According to Economic Times, around 1.5 lakh people succumbed to road accidents in India, accounting for highest road deaths in the globe. India artificial disc market is likely to be valued at USD 145 million by 2026, partly attributed to soaring geriatric population and trend for sedentary lifestyle. Access sample pages of the report, “Asia Pacific Artificial Disc Market Forecasts 2026” in detail along with the table of contents (ToC) @ https://www.graphicalresearch.com/request/1299/sample Cervical artificial disc adoption in APAC countries Industry participants in the region have shown inclination for cervical disc arthroplasty which helps in maintaining motion and relieve nerve compression. The cervical disc replacement procedure has gained ground considering it minimizes the risk of infection and ensures minimum blood loss. In terms of revenue, the cervical artificial disc segment was valued at over USD 160 million in 2019 and will expand with rising adoption of the procedure among the adult and the elderly population. Meanwhile, soaring cases of spinal degenerative disease (SDD) in China has prompted leading companies to infuse funds in the mainland. An upsurge in healthcare budgets has led to the advancements of healthcare facilities, auguring well for the industry outlook. Technological advancements and growing market presence of minimally invasive disc replacement procedures will bolster the global artificial disc industry value. About Graphical Research: Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle. CONTACT: Contact Us: Parikhit B. Corporate sales, Graphical Research Phone: 1-800-986-6917 Email: firstname.lastname@example.org Web: https://www.graphicalresearch.com
Researchers in British Columbia, Ontario, and Quebec will also study the effects of the pandemic on teachers’ mental healthMONTREAL, March 04, 2021 (GLOBE NEWSWIRE) -- As in-class learning has been affected in much of the country due to the COVID-19 pandemic, the Government of Canada, through its COVID-19 Immunity Task Force (CITF), is supporting three research projects that will estimate how many teachers and school personnel have been infected with SARS-CoV-2, the virus that causes COVID-19. Approximately $2.9 million has been provided for three studies, one each in Ontario, Quebec and British Columbia, to help further inform decision-making around prevention strategies in neighbourhoods, schools and daycares. This will also help with vaccine surveillance once vaccines are given to teaching personnel. The studies will also evaluate the effects of the pandemic on teachers’ mental health. All three studies will ask teachers and education workers for blood samples to establish how many have antibodies to SARS-CoV-2, which would indicate a previous COVID-19 infection. The studies will also ask participants to complete a questionnaire to determine both the risks they have faced and the protective measures they have taken, at the individual, household, school, and community levels. When a vaccine becomes available to education workers, these studies will determine how many teachers agree to be vaccinated and whether antibodies are detected in their blood after vaccination at several points in time. The Ontario study aims to enroll up to 7,000 teachers and education workers and will follow participants for 12 months to determine the factors associated with infection. “Blood tests are an important part of our study,” explains Dr. Brenda Coleman, PhD, researcher at Sinai Health and Assistant Professor at the Dalla Lana School of Public Health, University of Toronto. “They allow us to determine how many participants have already been exposed to the virus, how many become exposed between enrolment and the end of the study, whether vaccination induces antibodies, and whether antibody levels change over time. We also ask participants to fill out the questionnaires to assess levels of distress over time.” The study in British Columbia will focus on both staff and students within the Vancouver School District. It aims to determine how many staff members in Vancouver schools have already been infected with COVID-19 by checking blood samples for antibodies. The study will also examine the risk of exposure to the virus in schools and assess the impact of the pandemic on the mental health of staff members. “To get a more complete picture of how many people are exposed to the virus in schools, the research team will check blood samples from staff for antibodies indicating a previous exposure,” says lead researcher Dr. Pascal Lavoie, MD, PhD, investigator at the BC Children’s Hospital Research Institute, pediatrician, and Associate Professor in the Department of Pediatrics at the University of British Columbia (UBC). “Additionally, in the months to come, when a student or staff member has been declared positive for COVID-19, we will test their close contacts using a non-invasive mouth rinse gargle test that was first evaluated and implemented at BC Children’s Hospital.” The Quebec study will build on an existing CITF-funded study named EnCORE, which has been determining how many children and adolescents have had SARS-CoV-2 infections in four Montreal neighbourhoods. The new study will use the same schools and daycares being used for EnCORE in Beaconsfield, Hochelaga-Maisonneuve, Montreal-North and the Plateau, but will expand to include school staff. The study will determine how many daycare and school staff members have had SARS-CoV-2 and will measure how antibody levels fluctuate over the next six months. The study will also establish the prevalence of pandemic-related emotional and mental health issues among daycare and school personnel in Montreal. “Participation involves completing an online questionnaire to collect information on health, socio-demographics, COVID-19 prevention practices, and mental and emotional health,” explains project lead Dr. Kate Zinszer, PhD, Assistant Professor at l’École de santé publique, Université de Montréal, and researcher at the Public Health Research Institute. “We will also be asking whether they have received a vaccine, and which one, and incorporating this information into our analysis.” “Although daycare and school staff may have been exposed to SARS-CoV-2 in their work settings, we don’t have much data on how many school staff have had asymptomatic infections, meaning they had no symptoms but potentially could transmit the virus,” says Dr. Catherine Hankins, co-Chair of the CITF. “The pandemic has also had negative impacts on the mental health and wellbeing of daycare and school personnel for various reasons which the studies will document. Examples include feeling anxiety about the potential risk of SARS-CoV-2 infection, being responsible for ensuring compliance with infection control measures, and experiencing the disruption that the pandemic has had on their work and their workplace.” “These studies will help us understand more about COVID-19 infection among staff in educational settings,” says Dr. Theresa Tam, Chief Public Health Officer of Canada. “By including questionnaires that delve more deeply into teachers’ experiences, including their mental health, this research will help develop strategies to support the well-being of teachers and daycare staff.” Researchers will inform participating school staff if they have antibodies to SARS-CoV-2, although that still does not guarantee immunity against the virus that causes COVID-19. School personnel wishing to participate in one of the three studies can go to: Quebec study: encorestudy.ca, BC study: bcchr.ca/COVIDatschools, Ontario study: tibdn.ca/covid-19/education ABOUT THE COVID-19 IMMUNITY TASK FORCE In late April 2020, the Government of Canada established the COVID-19 Immunity Task Force with a two-year mandate. The Task Force is overseen by a Leadership Group of volunteers that includes leading Canadian scientists and experts from universities and healthcare facilities across Canada who are focused on understanding the nature of immunity arising from the novel coronavirus that causes COVID-19. To that end, the CITF is supporting numerous studies to determine the extent of SARS-CoV-2 infection in Canada (in the general population as well as in specific communities and priority populations), understand the nature of immunity following infection, develop improved antibody testing methods, and help monitor the effectiveness and safety of vaccines as they are rolled out across Canada. The Task Force and its Secretariat accordingly work closely with a range of partners, including governments, public health agencies, institutions, health organizations, research teams, other task forces, communities, and stakeholders. Most recently, the Task Force has been asked to take a major role in supporting vaccine surveillance for effectiveness and safety. Our overriding objective is to generate data and ideas that inform interventions aimed at slowing and ultimately stopping the spread of SARS-CoV-2 in Canada. For more information visit: www.covid19immunitytaskforce.ca MEDIA CONTACTS COVID-19 Immunity Task Force email@example.comRebecca BurnsCell: +1.438.871.8763BC Study Alan Worsley, Research Communications, BC Children’s HospitalCell: +1. 604. 219.4685Work: +1.604.875.2401Alan.Worsley@bcchr.ca Quebec study Jeff Heinrich, Université de Montréaljeff.firstname.lastname@example.org
Nokia Corporation Stock Exchange ReleaseMarch 4, 2021 at 12:00 (CET +1) Notice of the Annual General Meeting of Nokia Corporation Notice is given to the shareholders of Nokia Corporation (the "Company") of the Annual General Meeting to be held on Thursday April 8, 2021 at 3:00 p.m. in the Company’s headquarters at Karakaari 7, Espoo, Finland. Participation and exercise of shareholder rights in the Meeting is possible only by voting in advance and by submitting counterproposals and asking questions in advance in accordance with the instructions given in section C of this notice and otherwise by the Company. It is not possible for the shareholders or their proxy representatives to participate in the Meeting at the meeting venue. The Board of Directors of the Company has resolved on extraordinary measures pursuant to the legislative act concerning temporary deviations from the Companies Act (677/2020), which entered into force on October 3, 2020. In order to restrict the spread of the COVID-19 pandemic, the Annual General Meeting will be held without shareholders’ and their proxy representatives’ presence at the Meeting venue. This is necessary in order to ensure the health and safety of the shareholders, employees and other stakeholders of the Company as well as to organize the Meeting in a predictable way allowing equal means for shareholders to participate while also ensuring compliance with the current restrictions set by the authorities. It is possible to follow the Annual General Meeting through a webcast, provided that the webcast can be arranged in compliance with all regulatory rules and restrictions imposed by the Finnish authorities due to the COVID-19 pandemic. Instructions regarding the webcast will be available on the Company’s website www.nokia.com/agm. It is not possible to ask questions, make counterproposals or vote through the webcast, and following the webcast is not considered as participation or any kind of exercise of shareholder rights in the Meeting. A. Matters on the agenda of the Annual General Meeting At the Annual General Meeting, the following matters will be considered: 1. Opening of the Meeting 2. Matters of order for the Meeting The Chair of the Meeting will be Seppo Kymäläinen, attorney-at-law. In case Seppo Kymäläinen would not be able to act as the Chair of the Meeting for a weighty reason, the Board of Directors will name another person it deems most suitable to act as the Chair of the Meeting. 3. Election of a person to confirm the minutes and a person to verify the counting of votes The person to confirm the minutes and to verify the counting of votes will be Ulla Nyberg, the Company’s Senior Legal Counsel. In case Ulla Nyberg would not be able to act as the person to confirm the minutes and to verify the counting of votes for a weighty reason, the Board of Directors will name another person it deems most suitable to act in that role. 4. Recording the legal convening of the Meeting and quorum 5. Recording the attendance at the Meeting and adoption of the list of votes The shareholders who have voted in advance and who have the right to participate in the Meeting pursuant to Chapter 5 Sections 6 and 6a of the Finnish Limited Liability Companies Act will be recorded to have attended the Meeting. The list of votes will be adopted according to the information provided by Euroclear Finland Oy. 6. Presentation of the Annual Accounts, the review by the Board of Directors and the auditor’s report for the financial year 2020 As participation in the Meeting is possible only in advance, the “Nokia in 2020” annual report, which includes the Company’s Annual Accounts, the review by the Board of Directors and the auditor’s report is deemed to have been presented to the Meeting once it is published in week 9 of 2021, after which it is available on the Company’s website www.nokia.com/agm. 7. Adoption of the Annual Accounts The Board of Directors proposes that the Annual General Meeting adopt the Annual Accounts. 8. Resolution on the use of the profit shown on the balance sheet Both Nokia Corporation and the Nokia Group reported a loss for the financial year 2020. While Nokia has strengthened its cash position, the Board of Directors continues to focus on ensuring Nokia’s ability to increase investments in 5G and strategic areas, while continuing to establish a track record of sustainable cash generation. Therefore, the Board of Directors proposes to the Meeting that no dividend be paid based on the balance sheet to be adopted for the financial year ended on December 31, 2020. 9. Resolution on the discharge of the members of the Board of Directors and the President and CEO from liability for the financial year 2020 10. Addressing the Remuneration Report As participation in the Meeting is possible only in advance, the Remuneration Report is deemed to have been presented to the Meeting once it has been published by a stock exchange release in week 9 of 2021, after which it is available on the Company’s website www.nokia.com/agm. The resolution to adopt the Remuneration Report is advisory. 11. Resolution on the remuneration to the members of the Board of Directors The Board’s Corporate Governance and Nomination Committee has made a recommendation to the Board to introduce additional annual fees to be paid to the members of the Personnel Committee and Technology Committee in addition to the Committee Chairs. Other remuneration payable to the Board members would remain unchanged and no additional annual fee payable to the Committee members is proposed to be paid to the members of the Corporate Governance and Nomination Committee or the Chair of the Board for her service in any of the Board Committees. Consequently, on the recommendation of the Board’s Corporate Governance and Nomination Committee, and in line with the Company’s Remuneration Policy presented to and adopted by the Annual General Meeting 2020, the Board of Directors proposes to the Annual General Meeting that the annual fees payable for a term ending at the close of the next Annual General Meeting be as follows: EUR 440 000 for the Chair of the Board;EUR 185 000 for the Vice Chair of the Board;EUR 160 000 for each member of the Board;EUR 30 000 each for the Chairs of the Audit Committee and Personnel Committee and EUR 20 000 for the Chair of the Technology Committee as an additional annual fee; andEUR 15 000 for each member of the Audit Committee and Personnel Committee and EUR 10 000 for each member of the Technology Committee as an additional annual fee. In addition, the Board proposes that the meeting fees for Board and Board Committee meetings payable to all the other Board members, except for the Chair of the Board, remain at current level. These meeting fees based on travel required between the Board member’s home location and the location of a meeting would be paid for a maximum of seven meetings per term as follows: EUR 5 000 per meeting requiring intercontinental travel; andEUR 2 000 per meeting requiring continental travel. Only one meeting fee would be payable in the usual case of multiple Board and Board Committee meetings per eligible travel. Furthermore, the Board also proposes that members of the Board of Directors shall be compensated for travel and accommodation expenses as well as other costs directly related to Board and Board Committee work. It is proposed that approximately 40 per cent of the annual fee be paid in Nokia shares purchased from the market, or alternatively by using treasury shares held by the Company. The meeting fee, travel expenses and other expenses would be paid in cash. 12. Resolution on the number of members of the Board of Directors On the recommendation of the Board’s Corporate Governance and Nomination Committee, the Board proposes to the Annual General Meeting that the number of Board members be eight (8). 13. Election of members of the Board of Directors Elizabeth Nelson has informed that she will no longer be available to serve on the Nokia Board of Directors after the Annual General Meeting. The Board proposes, on the recommendation of the Board’s Corporate Governance and Nomination Committee, that the following eight current Board members be re-elected as members of the Nokia Board of Directors for a term ending at the close of the next Annual General Meeting: Sari Baldauf, Bruce Brown, Thomas Dannenfeldt, Jeanette Horan, Edward Kozel, Søren Skou, Carla Smits-Nusteling, and Kari Stadigh. All candidates for the Board of Directors and evaluation on their independence are presented on the Company’s website www.nokia.com/agm. 14. Resolution on the remuneration of the Auditor On the recommendation of the Board’s Audit Committee, the Board of Directors proposes to the Meeting that the auditor to be elected for the financial year 2022 be reimbursed based on the invoice of the auditor and in compliance with the purchase policy approved by the Audit Committee. 15. Election of Auditor for the financial year 2022 Since 2019 the Board of Directors has proposed to the Annual General Meeting that the shareholders would elect the auditor for the financial year commencing next after the election. Therefore, on the recommendation of the Board’s Audit Committee, the Board of Directors proposes to the Meeting that Deloitte Oy be re-elected as the auditor of the Company for the financial year 2022. Deloitte Oy has informed the Company that in the event it is re-elected as the auditor, the auditor in charge will be Authorized Public Accountant Marika Nevalainen. 16. Authorization to the Board of Directors to resolve to repurchase the Company’s own shares The Board of Directors proposes that the Meeting authorize the Board to resolve to repurchase a maximum of 550 million shares, which corresponds to less than 10 per cent of the Company’s total number of shares. The repurchases under the authorization are proposed to be carried out by using funds in the unrestricted equity, as resolved by the Board, which means that the repurchases will reduce distributable funds of the Company. The price paid for the shares under the authorization shall be based on the market price of Nokia shares on the securities markets on the date of the repurchase. Shares may be repurchased to be cancelled, held to be reissued, transferred further or for other purposes resolved by the Board. The Company may enter into derivative, share lending or other arrangements customary in capital market practice. The shares may be repurchased otherwise than in proportion to the shares held by the shareholders (directed repurchase). The Board shall resolve on all other matters related to the repurchase of Nokia shares. It is proposed that the authorization be effective until October 7, 2022 and terminate the authorization for repurchasing the Company’s shares granted by the Annual General Meeting on May 27, 2020. 17. Authorization to the Board of Directors to resolve to issue shares and special rights entitling to shares The Board proposes that the Annual General Meeting authorize the Board to resolve to issue in total a maximum of 550 million shares through issuance of shares or special rights entitling to shares under Chapter 10, Section 1 of the Finnish Limited Liability Companies Act in one or more issues during the effective period of the authorization. The Board may issue either new shares or treasury shares held by the Company. The proposed maximum amount corresponds to less than 10 per cent of the Company’s total number of shares as of the date of this proposal. Shares and special rights entitling to shares may be issued in deviation from the shareholders’ pre-emptive rights as a directed share issue within the limits set by law. The authorization may be used to develop the Company’s capital structure, diversify the shareholder base, finance or carry out acquisitions or other arrangements, to settle the Company’s equity-based incentive plans or for other purposes resolved by the Board. The Board would resolve on all terms and conditions of the issuance of shares and special rights entitling to shares under Chapter 10, Section 1 of the Finnish Limited Liability Companies Act. It is proposed that the authorization be effective until October 7, 2022 and terminate the authorization for issuance of shares and special rights entitling to shares resolved at the Annual General Meeting on May 27, 2020. 18. Closing of the Meeting B. Documents of the Annual General Meeting This notice, all the proposals by the Board of Directors relating to the agenda of Meeting, the Remuneration Report as well as the “Nokia in 2020” annual report, which includes the Company’s Annual Accounts, the review by the Board of Directors and the auditor’s report, are expected to be available on the Company’s website at www.nokia.com/agm in week 9 of 2021. The “Nokia in 2020” annual report will be sent to shareholders upon request. The minutes of the Annual General Meeting will be available on the Company’s website www.nokia.com/agm latest on April 22, 2021. C. Instructions for the participants of the Annual General Meeting The Company takes the threat of the COVID-19 pandemic seriously, and in its efforts to prevent the spread of the COVID-19 pandemic, the Annual General Meeting has been decided to be held without shareholders and their proxy representatives’ presence at the Meeting venue. This is necessary especially in order to ensure the health and safety of the Company's shareholders, employees and other stakeholders. The Company’s shareholders and their proxies can participate in the Meeting and use their shareholder rights only by voting in advance and by submitting counterproposals and asking questions in advance by following the below instructions. It is possible to follow the Annual General Meeting through a webcast, provided that the webcast can be arranged in compliance with all regulatory rules and restrictions imposed by the Finnish authorities due to the COVID-19 pandemic. Instructions regarding the webcast will be available on the Company’s website www.nokia.com/agm. It is not possible to ask questions, make counterproposals or vote through the webcast, and following the webcast without voting in advance, or issuing a proxy related thereto, is not considered as participation or any kind of exercise of shareholder rights in the Meeting. 1. The right to participate in the Meeting Each shareholder, who on March 25, 2021 is registered in the Register of Shareholders of the Company, maintained by Euroclear Finland Oy, has the right to participate in the Annual General Meeting. A shareholder, whose shares are registered on his/her Finnish book-entry account, is automatically registered in the Register of Shareholders of the Company. If you do not have a Finnish book-entry account, see section 4. Holders of nominee-registered shares or section 5. Holders of American Depositary Receipts (ADR). Shareholders cannot participate in the Meeting by any other means than voting in advance in the manner instructed below as well as by submitting counterproposals and asking questions in advance. 2. Registration and voting in advance for shareholders registered in the shareholders’ register maintained by Euroclear Finland Oy Shareholders with a Finnish book-entry account, who wish to participate at the Annual General Meeting, must register for the Meeting by giving a prior notice of participation and by delivering their votes in advance no later than by March 30, 2021 at 4:00 p.m. (EET) by which time the notice and votes need to be received. Registration and advance voting will open on March 10, 2021 by 10:00 a.m. and end on March 30, 2021 at 4:00 p.m. (EET). A shareholder, who has a Finnish book-entry account, may register and vote in advance by the following means: a) through the Company's website at www.nokia.com/agm Private persons can register and vote by using strong authentication (for example Finnish bank ID). For legal persons, a business ID and the book-entry account number of the shareholder are needed for voting in advance. b) by email or mail A shareholder may send the advance voting form available on the Company’s website to Euroclear Finland Oy by email at email@example.com or by regular mail to Euroclear Finland Oy, Yhtiökokous/Nokia Oyj, P.O. Box 1110, FI-00101 Helsinki. In connection with the registration, a shareholder or a proxy representative is required to provide the personal information requested. The personal information collected will only be used in connection with the Annual General Meeting and registrations related to it. If a shareholder participates in the Meeting by sending the votes in advance by mail or email to Euroclear Finland Oy, in accordance with applicable instructions, the delivery of the votes constitutes due registration for the Meeting. No other separate notification of participation is required. Further instructions relating to the advance voting will be available on the Company's website www.nokia.com/agm and information is also available by telephone at +358 20 770 6870 from Monday to Friday at 9:00 a.m. to 4:00 p.m. (EET). 3. Proxy representatives and powers of attorney A shareholder may participate in the Annual General Meeting by proxy. The proxy representative of a shareholder is also required to vote in advance in the manner instructed in this notice. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate their right to represent the shareholder. Should a shareholder participate in the Meeting by means of several proxy representatives representing the shareholder with shares in different book-entry accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Meeting. Proxy authorization documents should be delivered to Euroclear Finland Oy by letter to Euroclear Finland Oy, Yhtiökokous/Nokia Oyj, P.O. Box 1110, FI-00101 Helsinki or by email at firstname.lastname@example.org at the latest by March 30, 2021 at 4:00 p.m. (EET). 4. Holders of nominee-registered shares A holder of nominee-registered shares has the right to participate in the Annual General Meeting by virtue of such shares, based on which they on the record date of the Annual General Meeting, i.e. on March 25, 2021, would be entitled to be registered in the shareholders’ register of the company held by Euroclear Finland Oy. The right to participate in the Meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Oy at the latest by April 1, 2021 by 2:00 p.m. (EET). As regards nominee-registered shares this constitutes due registration for the Annual General Meeting. A holder of nominee-registered shares is advised to request without delay necessary instructions regarding the temporary registration in the shareholders’ register of the company, the issuing of proxy documents and registration for the AGM from his/her custodian bank. The account management organization of the custodian bank shall temporarily register a holder of nominee-registered shares, who wants to participate in the AGM, into the shareholders’ register of the company at the latest by the time stated above. In addition, the account management organization of the custodian bank shall arrange advance voting on behalf of the holders of nominee registered shares. Further information on these matters can also be found on the company’s website www.nokia.com/agm. 5. Holders of American Depositary Receipts (ADR) A holder of American Depositary Shares (ADR) intending to vote at the Meeting shall without delay notify the Depositary Bank of Nokia, Citibank, N.A., of his/her intention and shall comply with the instructions provided by Citibank, N.A. 6. Other instructions and information Shareholders who hold at least 1/100 of all shares in the Company have a right to make counterproposals on the agenda items for the Meeting, to be put for a vote. Such counterproposals are required to be sent to the Company by email to email@example.com no later than by March 9, 2021 at noon (EET). The shareholders shall in connection with the counterproposal present sufficient evidence of their shareholding in the Company. The counterproposal will be taken to a vote in the Meeting provided that the shareholders making the counterproposal have the right to participate in the Meeting and that they hold at least 1/100 of all outstanding shares in the Company on the record date of the Meeting. Should the counterproposal not be taken to a vote at the Meeting, votes in favor of the counterproposal will not be taken into account. The Company will publish the counterproposals eligible for voting on the Company’s website www.nokia.com/agm on March 10, 2021 at the latest. Shareholders have the right to ask questions referred to in Chapter 5, Section 25 of the Finnish Limited Liability Companies Act with respect to the matters to be considered at the Meeting. Such questions must be sent by email to firstname.lastname@example.org no later than March 19, 2021 at 4:00 p.m. (EET). Shareholders shall in connection with their questions present sufficient evidence of their shareholding in the Company. Such questions from shareholders, the Company’s management’s answers to them, and any counterproposals that have not been considered to be put for a vote are available on the Company’s website www.nokia.com/agm on March 24, 2021. Information on the General Meeting required by the Finnish Limited Liability Companies Act and the Securities Markets Act is available on the Company’s website www.nokia.com/agm. Changes in the number of shares held after the record date of the Annual General Meeting shall not have an effect on the right to participate the Meeting nor on the number of votes held by a shareholder in the Meeting. On the date of this notice of the Annual General Meeting the total number of shares in Nokia Corporation and votes represented by such shares is 5 675 461 159. BOARD OF DIRECTORS About Nokia We create the critical networks and technologies to bring together the world’s intelligence, across businesses, cities, supply chains and societies. With our commitment to innovation and technology leadership, driven by the award-winning Nokia Bell Labs, we deliver networks at the limits of science across mobile, infrastructure, cloud, and enabling technologies. Adhering to the highest standards of integrity and security, we help build the capabilities we need for a more productive, sustainable and inclusive world. For our latest updates, please visit us online www.nokia.com and follow us on Twitter @nokia. Media Enquiries:Nokia CommunicationsTel. +358 (0) 10 448 4900Email: email@example.comKatja Antila, Head of Media Relations Investor Enquiries:Nokia Investor RelationsTel. +358 4080 3 4080Email: firstname.lastname@example.org
VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- If governments in Canada want to encourage innovation and entrepreneurship (and increase the possibility of a four-day work week), they should eliminate trade barriers, ease restrictions on foreign investment, lower taxes and reduce regulation, finds a new essay released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank. “Rates of entrepreneurship have been declining in Canada, and given the close link between entrepreneurship and productivity growth, if policymakers across the country want to increase productivity, they should enact policies that better incentivize new business ventures,” said Russell S. Sobel, professor of economics and entrepreneurship at The Citadel and author of Enhancing Productivity Growth by Encouraging Entrepreneurship. For example, because high tax rates lower the return on entrepreneurial activity, governments can help spur entrepreneurship, innovation and productivity by reducing tax rates. Moreover, governments could reduce or eliminate regulatory hurdles (permit processes and costs, for example) that make it more costly and difficult for Canadians to start new businesses and/or compete with larger firms, which have the resources (including tax and legal departments) to better navigate the regulatory process. Finally, Canadian governments—including the federal government—could help increase productivity by lowering domestic and international trade barriers so entrepreneurs can sell their products or services in larger markets. A separate related essay examines how restrictions on competition discourage innovation, thereby slowing productivity growth and limiting the possibility of a four-day work week. “When governments—intentionally or not—use tariffs, foreign ownership restrictions and high regulatory hurdles to suppress market competition, the overall economy, which relies heavily on entrepreneurship and innovation, suffers,” said Steven Globerman, professor emeritus at Western Washington University, Fraser Institute senior fellow and author of Promoting Productivity Growth by Encouraging Innovation. And a third essay, Entrepreneurial Finance and Productivity in Different Institutional Contexts: Lessons from Equity Crowdfunding, by Douglas Cumming, professor of finance and entrepreneurship at Florida Atlantic University, notes how Canada regulates non-traditional capital markets more than other jurisdictions, which can also frustrate startup businesses. These essays are part of a series published by the Fraser Institute, which focuses on policy reforms that can improve productivity growth and lay the foundation for a four-day work week. MEDIA CONTACTS: Russell S. Sobel, Professor of Economics and Entrepreneurship, The Citadel Steven Globerman, Senior Fellow, Fraser Institute To arrange media interviews or for more information, please contact:Mark Hasiuk, Senior Media Relations Specialist, 604-688-0221 ext. 517, email@example.com Follow the Fraser Institute on Twitter | Like us on Facebook The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute’s independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org
The Board of Directors in Norwegian Finans Holding ASA (“the Company”) refers to the announcement at 08.00 CET at 4 March, where Nordax Bank AB announces its intention to launch a voluntary offer for the shares in the company. The Board of Directors will consider any offer launched. Shareholders are advised to refrain from taking any action in respect of their shares in the Company, before the Board of Directors has given their recommendation, and to exercise caution when dealing in the shares of the Company. Such actions may be prejudicial to shareholders interests. There can be no certainty that any offer will be made or completed. Further announcements will be made as required. For any questions please call: Klaus-Anders Nysteen, Chairman of the Board of Directors, phone: +47 99 26 56 91 / + 46 72-566 54 15 Tine Wollebekk, CEO, phone: +47 40 80 55 57 Klara-Lise Aasen, CFO, phone: +47 47 63 55 83 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Calgary, Alberta--(Newsfile Corp. - March 4, 2021) - Canadian Natural Resources Limited (TSX: CNQ) (NYSE: CNQ) announces its Board of Directors has declared a quarterly cash dividend on its common shares of C$0.47 (forty-seven cents) ...
Calgary, Alberta--(Newsfile Corp. - March 4, 2021) - Commenting on the Company's 2020 results, Tim McKay, President of Canadian Natural (TSX: CNQ) (NYSE: CNQ) stated "The impact of the COVID-19 pandemic effected the very way we conducted our lives and the way we operated our businesses. Through the year we took protocols to protect our stakeholders and would like to thank our employees, contractors, suppliers and shareholders for their support through this challenging year. ...
Last year, the city commissioned a study that ultimately pointed out the Columbia area had some of the highest taxes in the state. Now City Council is considering creating a committee to tackle the issue.
Top Players Covered in the Autism Spectrum Disorder Therapeutics Market Research Report Applied Behavior Consultants, Allergan, Pfizer Inc., Q BioMed Inc, Fusion Autism Cente, AstraZeneca, Hopebridge, LLC., Johnson & Johnson Services, Inc., Behavior Innovations, Eli Lilly and Company, Otsuka Holdings Co. Ltd. and other key market playersPune, India, March 04, 2021 (GLOBE NEWSWIRE) -- According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market”: Global Market Analysis, Insights and Forecast, 2018-2026,” the global market is likely to reach US$ 4,612.1 Mn by 2026 owing to the rising incidence of autism spectrum disorder worldwide. The report provides valuable insights into the global market trends and factors that are directly affecting the growth of the market. As per the report, the global autism spectrum disorder therapeutics market was worth US$ 3,293.0 Mn in 2018. Considering the increasing awareness programs regarding this particular disorder and less availability of treatment options, the global market is expected to rise at a moderate CAGR of 4.3% during the forecast period (2019-2026). The report further states that the number of children diagnosed with autism is increasing day by day across the globe. This, combined with favorable reimbursement scenario, will increase the demand for applied behavioral analysis therapies. Such therapies aid in improving learning and physical disabilities in autistic children. Furthermore, FDA approvals of numerous medicines that are used to manage autism spectrum disorder are expected to propel the global autism spectrum disorder therapeutics market during the forecast period. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autism-spectrum-disorder-therapeutics-market-101207 Autistic Disorder Segment to Witness Growth Owing to the Rising Prevalence of the Disease The global autism spectrum disorder therapeutics market is grouped into drug therapy and communication and behavioral therapy in terms of treatment type. Amongst these, the communication and behavioral therapy segment was in the leading position in the global market. Fortune Business Insights predicts that it will retain its position throughout the forecast period. In terms of type, the autism spectrum disorder therapeutics market is classified into Asperger syndrome, autistic disorder, pervasive development disorder, and others. Out of these, the autistic disorder segment procured the highest autism spectrum disorder therapeutics market share in the year 2018. It is anticipated to witness significant growth in the coming years. This growth is attributed to the increasing prevalence of this disorder. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207 Fusion Autism Center Opens its New Therapy Center to Provide Pediatric Services Several renowned market players have begun investing huge sums in the research and development of advanced and effective drugs for the treatment of autism spectrum disorder. This will contribute to the global autism spectrum disorder therapeutics market growth in the coming years. Below are three latest initiatives that have been recently taken by the prominent market players to drive global market sales. Fusion Autism Center (FAC), a mental health service provider, based in the U.S.A., announced in February 2019 that it has successfully expanded its center-based services of Applied Behavioral Analysis therapy for kids on the autism spectrum. The new center is built in Augusta so that it would provide much-needed services to the communities with special needs residing in the area. Apart from that, FAC has its centers in Roswell, Woodstock, Cumming, Peachtree, and Duluth. Quick Buy Autism Spectrum Disorder Therapeutics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101207 Q BioMed Inc., a prominent developer of biomedical assets, based in New York, announced in June 2018 that it has applied for Orphan Drug status with European and the U.S. regulators for QBM-001, the company’s pediatric autism drug. F. Hoffmann-La Roche Ltd., a multinational healthcare company, headquartered in Switzerland, announced that the FDA has approved Breakthrough Therapy Designation for its oral medication balovaptan in January 2018. The investigational oral medicine has the potential to improve communication and interaction abilities of those affected with autism spectrum disorder. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/autism-spectrum-disorder-therapeutics-market-101207 List of the Companies Profiled in the Global Market: Applied Behavior Consultants, Allergan, Pfizer Inc., Q BioMed Inc, Fusion Autism Center, AstraZeneca, Hopebridge, LLC., Johnson & Johnson Services, Inc., Behavior Innovations, Eli Lilly and Company, Otsuka Holdings Co. Ltd., other prominent market players. Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/autism-spectrum-disorder-therapeutics-market-101207 Detailed Table of Content: Introduction Research ScopeMarket SegmentationResearch MethodologyDefinitions and Assumptions Executive SummaryMarket Dynamics Market DriversMarket RestraintsMarket Opportunities Key Insights Prevalence of Autism Spectrum Disorder for Key Countries/Region Recent Industry Developments Such As Partnerships, Mergers, & Acquisitions Regulatory Framework by Key Countries Global Reimbursement Scenario and Economic Cost Burden for the Treatment of Autism Spectrum Disorder by Key Countries/Region Global Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Type Autistic DisorderAsperger SyndromePervasive Developmental DisorderOthers Market Analysis, Insights and Forecast – By Treatment Type Communication & Behavioral Therapies Applied behavior analysis (ABA)Speech & Language TherapyOccupational TherapyOthers Drug Therapies Antipsychotic DrugsSSRISStimulantsSleep MedicationsOthers Market Analysis, Insights and Forecast – By Region North AmericaEuropeAsia pacificLatin AmericaMiddle East & Africa TOC Continued…!! Have a Look at Related Reports: MicroRNA Market Size, Share & Covid-19 Impact Analysis, By Product (Instruments and Kits & Reagents) By Application (Isolation & Purification, Detection & Quantification, Disease Diagnostics, and Others) and By End User (Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, and Others), Regional Forecast, 2020-2027 Nurse Call Systems Company Size, Share & Industry Analysis, By Technology (Wired, Wireless), By Product (Basic Button Based Systems, Mobile Integrated Systems, IP Based Systems, Others), By End-user (Hospitals and Clinics, Assisted Living and Nursing Centres, Home Care Setting, Others), and Regional Forecast, 2019 – 2026 Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027 Active Wound Care Market Share and Industry Analysis by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings, Others), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), By End User (Hospitals, Clinics, Home Care Settings), and Regional Forecast 2018-2025 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: firstname.lastname@example.orgFortune Business Insights™LinkedIn | Twitter | Blogs Press: https://www.fortunebusinessinsights.com/press-release/autism-spectrum-disorder-therapeutics-market-9236
Research crystallizes analysis of more than 1,000 knowledge workers and 500,000 digital conversations to help forge path for the future of knowledge work CHICAGO and LONDON, March 04, 2021 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today released research that finds just 23 percent of knowledge workers report their organization is ahead of the curve in digital capabilities to support knowledge work. The implications of this finding are far-reaching, as knowledge workers are often the drivers of workplace innovation through the application of their ideas, skills, experience, knowledge, and judgement. With some estimates counting knowledge professionals at more than 1 billion worldwide, the iManage report demonstrates the need for many organizations to sharpen their strategies for enabling their professionals to connect with, activate, use, and retain critical knowledge across their businesses. Key findings include: 68 percent of knowledge workers believe “the information contained in digital documents and files” is vital to their business. Respondents rated contracts, emails, and spreadsheets as the three most important sources of digital information74 percent believe knowledge work will be even more important to business in a post-COVID world47 percent of survey respondents state improving employee productivity and collaboration is one of their organization’s top goals28 percent of survey respondents said that most or all of their documents are scattered and siloed across multiple systems30 percent of respondents said that documents reach their organization via five or more channels Rapidly expanding knowledge assets and technology have changed the way we work, live and conduct business. With much of the global economy trading on intellectual capital rather than the production of tangible goods, workers’ knowledge or intellectual property may not be able to be physically seen or touched, but it holds tremendous value in driving business results and must be preserved, protected, and shared within the organizations it powers. A New Approach to Knowledge Work is the Key to Deriving Maximum Value“Really understanding how to make knowledge work achieve its highest and best use within organizations is a perspective shift that goes beyond enabling simple knowledge management. It requires putting into place an ecosystem for knowledge activation,” said Neil Araujo, CEO iManage. “Organizations must have a breadth of capabilities at work that include collaboration, secure storage and retrieval, ability to work from anywhere, and capacity to curate and repurpose institutional knowledge – all delivered though a high-performance, reliable cloud service. This empowers knowledge workers to create opportunities for unencumbered thinking, higher level productivity, and creativity that drives innovation and spurs new business opportunities.” Approaches to closing knowledge gaps have been fragmented, and crucial information has fallen through the cracks, taking critical value with it. When viewed in context of the exponential increases in data volume and data sources, the challenge is magnified. According to IDC, the amount of data created over the next three years will be more than the data created over the past 30 years, and the world will create more than three times the data over the next five years than it did in the previous five. Contextual Relevance is Essential for Effective Knowledge Work For many knowledge workers, the units of work they handle are large, complex, and often involve multiple people and teams. The collective intelligence amassed from collaborating across these diverse teams and projects, along with the unique expertise contributed by team members, forms an essential part of the institutional memory of an organization. Effective knowledge work platforms need to be able to contextualize knowledge created and gathered across enterprises over extensive periods of time to deliver the right information to the right knowledge professional at the right time. When information is siloed, scattered, or cannot be effectively identified and shared, it not only blocks productivity but can also negatively affect employee and customer satisfaction. Making relevant, contextual information fast and easy to find and activate is essential to improving productivity. Automation Technologies are UnderutilizedThe study also found that respondents’ organizations were slow to adopt automation technology. While Artificial Intelligence (AI) figured prominently in the digital conversations analyzed, less than 40 percent of those surveyed reported that their departments were using automation technologies of any kind when working with very important digital documents or files, and fewer than 37 percent were using automated workflows. By raising awareness of key drivers and influences shaping the future of the global knowledge work marketplace, iManage is helping companies and their professionals chart a course to maximize the impact of knowledge work. More About the ReportThe multi-layered research, conducted by Metia Group’s insight unit, combines elements of Metia primary research with in-depth research commissioned by iManage. Findings are based on qualitative and quantitative analysis of more than 500,000 global, digital conversations over two years, alongside dozens of in-depth interviews with subject matter experts, as well as quantitative survey results from a sample of 1,068 businesses across the US and UK. A complimentary white paper reporting some of the key findings can be downloaded here. Follow iManage via: LinkedIn: https://www.linkedin.com/company/imanage Twitter: https://twitter.com/imanageinc Blog: https://imanage.com/blog/ About iManage iManage is the company dedicated to Making Knowledge Work™. Its intelligent, cloud-enabled, secure knowledge work platform enables organizations to uncover and activate the knowledge that exists inside their business content and communications. Advanced Artificial Intelligence and powerful document and email management create connections across data, systems, and people while leveraging the context of organizational content to fuel deep insights, informed business decisions, and collaboration. Underpinned by best-of-breed security and sophisticated workflows and governance approaches, iManage has earned its place as the industry standard by continually innovating to solve complex professional challenges and enabling better business outcomes for over one million professionals across 65+ countries. Visit www.imanage.com/ to learn more. Press Contact Information:Anastasia BullingeriManage Phone: +1 312 868 email@example.com
The 83-year-old ruling emir of Kuwait flew on Thursday to the United States for medical checks, state-run media reported, just months after he ascended the throne. State-run KUNA news agency described the purpose of Sheikh Nawaf Al Ahmad Al Sabah’s visit to the U.S. as “the usual medical check-ups,” without elaborating. After his predecessor, Sheikh Sabah Al Ahmad Al Sabah, fell ill last summer, a U.S. Air Force C-17 flying hospital ferried him to Rochester, Minnesota, home of the flagship campus of the Mayo Clinic, where he later died.
LONDON — Regulators in the U.K. and four other countries have announced new rules to fast-track the development of modified COVID-19 vaccines to ensure drugmakers can move swiftly to target emerging variants of the disease. Previously authorized vaccines that are modified to combat new variants “will not need a brand new approval or ‘lengthy’ clinical studies,” Britain’s Medicines and Healthcare Products Regulatory Agency said Thursday. “The clear goal is that future vaccine modifications that respond to the new variants of coronavirus can be made available in the shortest possible time to U.K. recipients without compromising at any stage on safety, quality or effectiveness,” Dr. June Raine, the head of the agency, said in a briefing for reporters. The new guidance is based on the model already used to modify the seasonal flu vaccine to keep up with annual changes in the virus and was issued jointly by regulators in the U.K., Australia, Canada, Singapore and Switzerland. The U.S. Food and Drug Administration and European Medicines Agency have issued similar guidance. Under the new rules, developers will be required to provide “robust evidence” that modified COVID-19 vaccines produce a strong immune response to the variant, as well as data showing they are safe and meet quality standards. This means developers will be required to carry out small-scale trials on a few hundred people, rather than the trials in tens of thousands of individuals that were required for initial approval, said Dr. Christian Schneider, the MHRA's chief scientific officer. “I’d like to emphasize that to date we don’t have evidence that the vaccines in use in the U.K. are significantly lacking in effectiveness,” Raine said. The announcement comes amid concerns that the virus that causes COVID-19 may mutate to create new variants that are resistant to existing vaccines. The U.K. has banned direct flights from 33 countries in an effort to prevent variants first discovered in Brazil and South Africa from becoming established in Britain. Vaccine makers have already been developing booster shots to target the new variants. Moderna said Feb. 24 that it had shipped a variant-specific vaccine candidate to the U.S. National Institutes of Health for review. The coronavirus pandemic has infected over 115 million people around the world and killed at least 2.5 million, according to Johns Hopkins University. ___ Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic,https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak Danica Kirka, The Associated Press
Ethiopia’s government is under growing pressure to allow the world to see firsthand what has occurred in its embattled Tigray region as its Nobel Peace Prize-winning prime minister rejects “partisan interventions.” Millions of dollars in aid to Ethiopia, a key security ally in the region, are at stake. Last month The Associated Press exposed the killing of an estimated 800 people in the city of Axum, citing several witnesses, and a week later Amnesty International reported “many hundreds” killed there, citing more than 40 witnesses.
Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "2021 Organic Sesame Seed Market - Size, Share, COVID Impact Analysis and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive research with in-depth data and contemporary analysis of Organic Sesame Seed Market at a global, regional and key country level, split by different sub-segments of the industry. The report presents growth projections in the Organic Sesame Seed Market between 2021 and 2027 for companies operating across different types, applications, and end-user verticals.Organic Sesame Seed Market is quickly reaching its pre-COVID levels and a healthy growth rate is expected over the forecast period driven by the V-shaped recovery in most of the developing nations.Key strategies of companies operating in Organic Sesame Seed Market Industry are identified as showcasing their contactless manufacturing and delivery methods, highlighting USP statements, focus on product packaging, and increased the presence of products on online platforms.The food industry is set to experience a few changes in 2021 due to the increased consciousness of consumers in selecting food. This inclination towards sustainable, regenerative, plant-based food and demand for foods and beverages with immunity-boosting ingredients is driving the demand for these products and their constituents. Do It Yourself (DIY) trend has seen huge momentum during Corona times and is expected to continue in 2021.Considering the rapidly changing market landscape, companies are changing their perspectives on expanding beyond traditional markets. In addition to focusing on widening applications, introducing new product portfolios, most food and beverage companies are planning to capture domestic and international markets.Fast pace recovery of developing economies leading to increased disposable income will support the Organic Sesame Seed Market demand between 2021 and 2027.Lockdowns across the globe in 2020 and continuing restrictions in 2021 disrupted the supply chain posing challenges for manufactures in the Organic Sesame Seed Market. Intense competition, pricing issues, and shifting consumer preferences will continue to put pressure on vendors' profit margins.Short-term and long-term trends affecting the market landscape are included in the research. Further, market drivers, restraints, and potential opportunities are also provided in the report.The Organic Sesame Seed report computes the 2020 market value in revenue terms based on the average Organic Sesame Seed prices and sales/revenue models of key companies operating in the Organic Sesame Seed Market Industry. The study forecasts the market size to 2027 for different types of Organic Sesame Seed and provides respective market share and growth rates.The study discusses technological innovations and the potential shift in demand among various products in the Organic Sesame Seed Market, over the forecast period. The leading five companies in the Organic Sesame Seed Market Industry together with their products, key strategies, and comparisons are provided.The Organic Sesame Seed Market size, share, and outlook across different types and applications are provided at geographic levels of North America, Asia Pacific, Europe, Middle East Africa, South and Central America. Further, country-level Organic Sesame Seed Market value is also provided.All recent developments in Organic Sesame Seed Market Industry including mergers, acquisitions, contract awards, licenses, product launches, and expansion plans are included in the report. Base Year - 2020; Forecast period: 2021 - 2027Publication frequency - Every six monthsResearch Methodology - Data triangulation with top-down and Bottom-up approach are used for market size Scope of the Report Global Organic Sesame Seed Market Industry size, 2020-2027Market trends, drivers, restraints, and opportunitiesPorter's Five forces analysisTypes of Organic Sesame Seed, 2020-2027Organic Sesame Seed applications and end-user verticals market size, 2020-2027Organic Sesame Seed Market size across countries, 2020-20275 leading companies in the industry - overview, key strategies, financials, and productsLatest market news and developments Key Topics Covered: 1. Table of Contents 2. Organic Sesame Seed Market Latest Trends, Drivers and Challenges, 2020 -20272.1 Organic Sesame Seed Market Overview2.2 Post COVID Strategies of Leading Organic Sesame Seed Companies2.3 Organic Sesame Seed Market Insights, 2021-20272.3.1 Leading Organic Sesame Seed types, 2021-20272.3.2 Leading Organic Sesame Seed End-User industries, 2021-20272.3.3 Fast-Growing countries for Organic Sesame Seed sales, 2021-20272.4 Organic Sesame Seed Market Drivers and Restraints2.4.1 Organic Sesame Seed Demand Drivers to 20272.4.2 Organic Sesame Seed Challenges to 20272.5 Organic Sesame Seed Market-Five Forces Analysis2.5.1 Organic Sesame Seed Industry Attractiveness Index, 20202.5.2 Threat of New Entrants2.5.3 Bargaining Power of Suppliers2.5.4 Bargaining Power of Buyers2.5.5 Intensity of Competitive Rivalry2.5.6 Threat of Substitutes3. Global Organic Sesame Seed Market Value, Market Share, and Forecast to 20273.1 Global Organic Sesame Seed Market Overview, 20203.2 Global Organic Sesame Seed Market Revenue and Forecast, 2021-2027 (US$ Million)3.3 Global Organic Sesame Seed Market Size and Share Outlook by Type, 2021-20273.4 Global Organic Sesame Seed Market Size and Share Outlook by End-User, 2021-20273.5 Global Organic Sesame Seed Market Size and Share Outlook by Region, 2021-20274. Asia Pacific Organic Sesame Seed Market Value, Market Share and Forecast to 20274.1 Asia Pacific Organic Sesame Seed Market Overview, 20204.2 Asia Pacific Organic Sesame Seed Market Revenue and Forecast, 2021-2027 (US$ Million)4.3 Asia Pacific Organic Sesame Seed Market Size and Share Outlook by Type, 2021-20274.4 Asia Pacific Organic Sesame Seed Market Size and Share Outlook by End-User, 2021-20274.5 Asia Pacific Organic Sesame Seed Market Size and Share Outlook by Country, 2021-20274.6 Key Companies in Asia Pacific Organic Sesame Seed Market5. Europe Organic Sesame Seed Market Value, Market Share, and Forecast to 20275.1 Europe Organic Sesame Seed Market Overview, 20205.2 Europe Organic Sesame Seed Market Revenue and Forecast, 2021-2027 (US$ Million)5.3 Europe Organic Sesame Seed Market Size and Share Outlook by Type, 2021-20275.4 Europe Organic Sesame Seed Market Size and Share Outlook by End-User, 2021-20275.5 Europe Organic Sesame Seed Market Size and Share Outlook by Country, 2021-20275.6 Key Companies in Europe Organic Sesame Seed Market6. North America Organic Sesame Seed Market Value, Market Share and Forecast to 20276.1 North America Organic Sesame Seed Market Overview, 20206.2 North America Organic Sesame Seed Market Revenue and Forecast, 2021-2027 (US$ Million)6.3 North America Organic Sesame Seed Market Size and Share Outlook by Type, 2021-20276.4 North America Organic Sesame Seed Market Size and Share Outlook by End-User, 2021-20276.5 North America Organic Sesame Seed Market Size and Share Outlook by Country, 2021-20276.6 Key Companies in North America Organic Sesame Seed Market7. South and Central America Organic Sesame Seed Market Value, Market Share and Forecast to 20277.1 South and Central America Organic Sesame Seed Market Overview, 20207.2 South and Central America Organic Sesame Seed Market Revenue and Forecast, 2021-2027 (US$ Million)7.3 South and Central America Organic Sesame Seed Market Size and Share Outlook by Type, 2021-20277.4 South and Central America Organic Sesame Seed Market Size and Share Outlook by End-User, 2021-20277.5 South and Central America Organic Sesame Seed Market Size and Share Outlook by Country, 2021-20277.6 Key Companies in South and Central America Organic Sesame Seed Market8. Middle East Africa Organic Sesame Seed Market Value, Market Share and Forecast to 20278.1 Middle East Africa Organic Sesame Seed Market Overview, 20208.2 Middle East and Africa Organic Sesame Seed Market Revenue and Forecast, 2021-2027 (US$ Million)8.3 Middle East Africa Organic Sesame Seed Market Size and Share Outlook by Type, 2021-20278.4 Middle East Africa Organic Sesame Seed Market Size and Share Outlook by End-User, 2021-20278.5 Middle East Africa Organic Sesame Seed Market Size and Share Outlook by Country, 2021-20278.6 Key Companies in Middle East Africa Organic Sesame Seed Market9. Organic Sesame Seed Market Structure9.1 Key Players 9.2 Organic Sesame Seed Companies - Key Strategies and Financial Analysis9.2.1 Snapshot9.2.2 Business Description9.2.3 Products and Services9.2.4 Financial Analysis10. Organic Sesame Seed Industry Recent Developments11 Appendix11.1 Publisher Expertise11.2 Research Methodology11.3 Annual Subscription Plans11.4 Contact InformationFor more information about this report visit https://www.researchandmarkets.com/r/xwnth0 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Middle East and Africa LED Flashlight Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type, Product, and Application" report has been added to ResearchAndMarkets.com's offering.
Canadian dollar forecasts for the coming months have been raised by strategists, reflecting recent gains for the currency but also expectations commodity prices will benefit from the reopening of the global economy, a Reuters poll showed. Canada is a major producer of commodities, including oil, which has soared about 80% since November, helped by supply cuts from major producers and the prospect of stronger global economic growth this year as COVID-19 vaccines roll out. The United States expects to have enough vaccine for every American adult by the end of May. Canada's vaccination campaign is also ramping up after earlier supply disruptions.